Ivermectin Orifarm (Ivermectin)

Ivermectin binds to glutamate‑gated chloride channels that are present on the nerve and muscle cells of many invertebrates. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarises the cells, leading to paralysis and death of the parasite while sparing mammalian cells that lack these channels.

The dosage of Ivermectin Orifarm is determined by the prescribing clinician based on the specific indication, patient weight, age, and clinical condition. Healthcare providers follow established guidelines and adjust the regimen as needed for each individual case.

Safety data for Ivermectin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Ivermectin belongs to the macrocyclic lactone class and offers a broad spectrum against several nematodes and ectoparasites. Compared with older agents such as albendazole, it often requires a single dose for many indications, providing convenient administration, though choice of therapy depends on the specific parasite, resistance patterns and patient factors.

Ivermectin Orifarm should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ivermectin Orifarm is taken orally, usually as a tablet or capsule, with water. The exact administration instructions, including whether it should be taken with food, are provided by the prescribing clinician and should be followed precisely.

Serious adverse events, although rare, can include severe skin reactions such as Stevens‑Johnson syndrome, neurological complications like seizures or encephalopathy, and significant liver injury. Patients should seek immediate medical attention if they experience rash, neurological symptoms, or signs of liver dysfunction.

Ivermectin Orifarm is contraindicated in individuals with known hypersensitivity to ivermectin or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in pregnant women unless the therapeutic benefit justifies the potential risk.